Skip to main content
All lobbying filings

NATIONAL VENTURE CAPITAL ASSOCIATION

Lobbying for NATIONAL VENTURE CAPITAL ASSOCIATION

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$648,117.00
What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 22
  • Centers For Medicare and Medicaid Services (CMS)
  • Commerce, Dept of (DOC)
  • Commodity Futures Trading Commission (CFTC)
  • Defense, Dept of (DOD)
  • Energy, Dept of
  • Federal Trade Commission (FTC)
  • Financial Crimes Enforcement Network (FinCEN)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • Homeland Security, Dept of (DHS)
  • HOUSE OF REPRESENTATIVES
  • Internal Revenue Service (IRS)
  • Justice, Dept of (DOJ)
  • Natl Institute of Standards & Technology (NIST)
  • Natl Science Foundation (NSF)
  • Office of Science & Technology Policy (OSTP)
  • Patent & Trademark Office (PTO)
  • Securities & Exchange Commission (SEC)
  • SENATE
  • Small Business Administration (SBA)
  • Treasury, Dept of
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 12
  • S 445
    Carried Interest Fairness Act of 2025
  • HR 1091
    Carried Interest Fairness Act of 2025
  • S 695
    Small Business Investment Act of 2025
  • HR 1199
    Small Business Investment Act of 2025
  • S 866
    American Innovation and Jobs Act
  • HR 1990
    American Innovation and R&D Competitiveness Act of 2025
  • HR 1
    Lower Energy Costs Act
  • HR 3633
    Digital Asset Market Clarity Act
  • S 394
    GENIUS Act of 2025
  • HR 2392
    STABLE Act of 2025
  • HR 5376
    Impacts and Outcomes for Health Career Training Act
  • HR 2385
    CREATE AI Act of 2025
 Lobbying activity 12
Taxation/Internal Revenue Code

S. 445, The Carried Interest Fairness Act of 2025; H.R. 1091, The Carried Interest Fairness Act; S. 695, The Small Business Investment Act of 2025; H.R. 1199, The Small Business Investment Act of 2025; S. 866, The American Innovation and Jobs Act of 2025; H.R. 1990, The American Innovation and R&D Competitiveness Act of 2025; H.R. 1, The One Big Beautiful Bill Act of 2025; Public Law No. 115-97 (The Tax Cuts and Jobs Act); Energy Tax Credits included in Public Law No. 117-169 (The Inflation Reduction Act).

Banking

Regulation D and exempt offering framework; Emerging growth company and small cap company capital formation issues; Initial public offering and public company reporting issues; Venture Capital fund definition and private fund compliance issues; Blockchain regulatory and policy issues; Digital Asset Market Clarity (CLARITY) Act (H.R. 3633), GENIUS Act of 2025 (S.394), and STABLE Act of 2025 (H.R.2392); capital formation and JOBS Act modernization; Developing and Empowering our Aspiring Leaders (DEAL) Act; Improving Capital Allocation for Newcomers (ICAN) Act; Implementation of the Foreign Investment Risk Review Modernization Act; foreign outbound investment restrictions; FinCEN rule on Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers.

Immigration

Creation of a Startup Visa; International Entrepreneur Rule; H-1B Visas.

Energy/Nuclear

Energy tax credits included in H.R.1, The One Big Beautiful Bill Act; Energy permitting reform; ARPA-E.

Health Issues

Drug pricing issues; CMS reimbursement including Medicare coverage of innovative technology; streamlining the FDA approval process, implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; federal research funding, Advanced Research Project Agency- Health. AI in healthcare.

Copyright/Patent/Trademark

Intellectual property issues that impact startups.

Science/Technology

Basic research funding and technology commercialization issues; Artificial Intelligence policy issues, including implementation of the U.S. AI Action Plan; CREATE AI Act H.R.2385

Small Business

SBIR/STTR reauthorization; implementation of the Inflation Reduction Act (H.R.5376) Public Law No. 117-169; the SBIC accrual debenture license for critical technology investment funds

Labor Issues/Antitrust/Workplace

Antitrust and competition policy impacting startups; FTC rulemaking on Hart-Scott-Rodino premerger notification program; FTC-DOJ Merger Guidelines

Trade (domestic/foreign)

Monitor updated export control regulations.

Defense

Issues related to streamlining procurement through the Department of Defense; issues related to private capital and procurement as it relates to the FY2026 National Defense Authorization Act (NDAA).

Agriculture

Blockchain regulatory and policy issues; Digital Asset Market Clarity (CLARITY) Act (H.R. 3633), GENIUS Act of 2025 (S.394), and STABLE Act of 2025 (H.R.2392)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem